Viemed Healthcare (VMD) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

Viemed Healthcare (VMD) overview

Viemed Healthcare (VMD) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 270m and operating profit of USD 22.9m; the year-end share price was 7.43 USD and market capitalisation was USD 282m. Viemed Healthcare is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Viemed Healthcare's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 142mFY 2025
Share price7.43 USDFY 2025 year end
RevenueUSD 270mFY 2025
Operating profitUSD 22.9mFY 2025
Net earningsUSD 14.9mFY 2025
Market capitalisationUSD 282mFY 2025 year end

About Viemed Healthcare

Viemed Healthcare provides home medical equipment and post-acute healthcare services in the United States. Its offerings include home ventilation, respiratory disease management, oxygen therapy, neuromuscular care, sleep testing and sleep apnea treatment, and women’s health products such as breast pumps. The company also supplies related equipment and supplies and provides healthcare staffing and recruitment services to healthcare facilities.

Generate the Viemed Healthcare report

Viemed Healthcare is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Viemed Healthcare and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Viemed Healthcare

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.